sprite-preloader
Anzeige
Mehr »
Montag, 18.12.2017 Börsentäglich über 12.000 News von 575 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

Aktuelle News von FiercePharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrAnother Teva exec departs, leaving a generics experience void
FrPerrigo said to have bid for Merck KGaA consumer health biz
FrMerck's Keytruda misses the mark in stomach cancer study
FrBesieged Teva launches exclusive generic of Gilead's Viread
FrIs payer bureaucracy to blame for slow pickup of Gilead's Yescarta?
FrPfizer takes on Novartis, Lilly with new Xeljanz nod
FrNovartis loses top oncology exec Strigini to retirement
FrFiercePharmaAsia-Ono, Eisai, Sanofi and more
DoFDA puts BMS combo in fast lane for new kidney cancer use
DoNICE flip-flops to back J&J's Imbruvica in MCL
DoPfizer weighs 'strategic options' for its second Remicade biosim
DoDo pharma's exec pay policies boost drug prices?
DoTeva's stunner of a cost-cutting plan targets 14K jobs
MiSanofi looks for path forward with Dengvaxia as challenges mount
MiLilly builds $23B sales forecast on diabetes, cancer launches
MiNew threat to Shire's hemophilia biz? Its CEO's not worried
MiJ&J's Janssen Oncology lifts curtain on Cancer.com website
MiPharma TV ad spend jumps past 2016, led by AbbVie and Pfizer
MiGSK, now battling AstraZeneca, scores brand-new market for Nucala
DiTeva turnover continues with exit of former chaiman
DiSerum Institute talks up plan to go after blockbuster vaccines
DiExperts say flu vaccine might be just 10% effective this year
DiInsider trading case against Ackman, Valeant approaches trial
DiWhy are Shire shares down? Investors just don't understand: CEO
DiSanofi picks up approval for Humalog copycat Admelog